Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,049,716
+$1,642,394 QoQ
Shares Held
350,397
+7.5% QoQ
Ownership
0.181%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#80
of 561 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Derivatives in BMRN
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$2,971,500
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $400,660,289 across 59 Biotechnology names. BMRN ranks #5 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
131,996 | $122,461,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
93,287 | $46,338,451 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
90,348 | $25,746,469 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,910 | $23,014,861 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
350,397 | $20,049,716 | |
| 6 | EXEL |
Exelixis, Inc.
|
343,029 | $18,664,207 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
69,588 | $16,768,620 | |
| 8 | INCY |
Incyte Corp
|
136,684 | $15,494,498 |
All Filings in BMRN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,049,716 | 350,397 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,407,322 | 325,851 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,971,500 | 50,000 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $17,098,783 | 287,713 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,435,690 | 155,755 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $524,523 | 9,542 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $441,388 | 6,244 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $673,535 | 10,247 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $462,437 | 6,579 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,075 | 256 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $67,601 | 774 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $91,119 | 986 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $83,701 | 946 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $78,358 | 904 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $417,256 | 4,291 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $77,103 | 780 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $174,541 | 2,059 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $170,545 | 2,058 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $153,120 | 1,986 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $204,706 | 2,317 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $116,398 | 1,506 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $173,137 | 2,075 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $545,182 | 7,220 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,981 | 34 | Shares | Sole | 2021-02-11 | |
| 2020-03-31 | $1,325,889 | 15,691 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||